Share
Journal Information
Issue
Vol. 16. Issue 2.Pages 176-318 (March - April 2017)
Editorial
Intrahepatic Cholestasis of Pregnancy: New Diagnostic Insights
Kristina R. Chacko, Allan W. Wolkoff
Ann Hepatol. 2017;16:176-8
Open access
Hepatitis B Reactivation or Hepatitis C Exacerbation in Patients with Hematological Malignancies
Isaac Ruiz, Jean-Michel Pawlotsky
Ann Hepatol. 2017;16:179-81
Open access
Opinions
Perspectives on NASH Histology: Cellular Ballooning
Stephen Caldwell, Carolin Lackner
Ann Hepatol. 2017;16:182-4
Open access
Viewpoints
Hepatitis B and NAFLD: Lives Crossed
María Luisa Morales,, Carmen Sendra, Manuel Romero-Gómez
Ann Hepatol. 2017;16:185-7
Open access
Concise review
Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis
Mohammad Saeid Rezaee-Zavareh, Khashayar Hesamizadeh, Bita Behnava, Seyed Moayed Alavian, Mohammad Gholami-Fesharaki, Heidar Sharafi
Ann Hepatol. 2017;16:188-97
Open access
Original article
Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma
Maria Guarino, Marco Picardi, Anna Vitiello, Novella Pugliese, Matilde Rea, Valentina Cossiga, Fabrizio Pane, Nicola Caporaso, Filomena Morisco
Ann Hepatol. 2017;16:198-206
Open access
Lamivudine, Entecavir, or Tenofovir Treatment of Hepatitis B Infection: Effects on Calcium, Phosphate, FGF23 and Indicators of Bone Metabolism
Ramesh Saeedi, Ali Mojebi-Mogharar, Supna K. Sandhu, Joshua A. Dubland, Jo-Ann Ford, Masoud Yousefi, Morris Pudek, Daniel T. Holmes, ... Eric M. Yoshida
Ann Hepatol. 2017;16:207-14
Open access
Effect of Treatment with Direct Acting Antiviral on Glycemic Control in Patients with Diabetes Mellitus and Chronic Hepatitis C
Jonathan G. Stine, Javelle A. Wynter, Blake Niccum, Virginia Kelly, Stephen H. Caldwell, Neeral L. Shah
Ann Hepatol. 2017;16:215-20
Open access
High Prevalence of ITPA Alleles Associated with Ribavirin-Induced Hemolytic Anemia Among Mexican Population
Karina Gonzalez-Aldaco, Arturo Panduro, João R. Rebello Pinho, Erika Martinez-Lopez, Ketti Gleyzer, Nora A. Fierro, Sonia Roman
Ann Hepatol. 2017;16:221-9
Open access
Interaction of Gender and Hepatitis C in Risk of Chronic Renal Failure After Liver Transplantation
Ip Stephen, Trana Hussaini, Aliya Daulat, Nilufar Partovi, Siegfried R. Erb, Eric M. Yoshida, Vladimir Marquez
Ann Hepatol. 2017;16:230-5
Open access
Clinical Impact of Portal Vein Thrombosis Prior to Liver Transplantation: A Retrospective Cohort Study
Constantine J. Karvellas, Filipe S. Cardoso, Marco Senzolo, Malcolm Wells, Mansour G. Alghanem, Fayaz Handou, Lukasz Kwapisz, Norman M. Kneteman, ... Bandar Al-Judaibi
Ann Hepatol. 2017;16:236-46
Open access
Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B/C of Hepatocellular Carcinoma: A Single Centre Experience
Joy Varghese, Chandan Kumar Kedarisetty, Jayanthi Venkataraman, Vijaya Srinivasan, Thiruchunapalli Deepashree, Mangerira Chinnappa Uthappa, Kaliamurthy Ilankumaran, Sanjay Govil, ... Mohamed Rela
Ann Hepatol. 2017;16:247-54
Open access
Practical Considerations of Real Life of Hepatocellular Carcinoma in a Tertiary Center of Brazil
Sandra R. Almeida-Carvalho, Maria L. Gomes-Ferraz, Carla A. Loureiro-Matos, Antônio E. Benedito-Silva, Roberto J. Carvalho-Filho, Rogério Renato-Perez, Adriano Miziara-Gonzalez, Alcides A. Salzedas-Netto, ... Ivonete S. Souza-Silva
Ann Hepatol. 2017;16:255-62
Open access
The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib
Fernanda Branco, Regiane S.M. Alencar, Fernanda Volt, Giovana Sartori, Andressa Dode, Luciana Kikuchi, Claudia M. Tani, Aline L. Chagas, ... Angelo Alves de Mattos
Ann Hepatol. 2017;16:263-8
Open access
Age-Standardized Mortality Rates Related to Cirrhosis in Brazil from 2000 to 2012: A Nationwide Analysis
Hugo Perazzo, Antonio G. Pacheco, Raquel De Boni, Paula M. Luz, Juliana Fittipaldi, Sandra W. Cardoso, Beatriz Grinsztejn, Valdiléa G. Veloso
Ann Hepatol. 2017;16:269-78
Open access
A Randomized Controlled Trial of Procedural Techniques for Large Volume Paracentesis
Amy R. Shriver, Sean R. Rudnick, Nicolas M. Intagliata, Amanda M. Wang, Stephen H. Caldwell, Patrick G. Northup
Ann Hepatol. 2017;16:279-84
Open access
A New Paradigm in Gallstones Diseases and Marked Elevation of Transaminases: An Observational Study
Sara Campos, Nuno Silva, Armando Carvalho
Ann Hepatol. 2017;16:285-90
Open access
Identification of Matrix Metalloproteinase-2 and 9 as Biomarker of Intrahepatic Cholestasis of Pregnancy
Zhong Chen, Zongji Shen, Lingqing Hu, Mudan Lu, Yizhong Feng
Ann Hepatol. 2017;16:291-6
Open access
Cancer Stem Cells are Depolarized Relative to Normal Stem Cells Derived from Human Livers
Wendy Bautista, Jeremy Lipschitz, Andrew McKay, Gerald Y. Minuk
Ann Hepatol. 2017;16:297-303
Open access
Images in hepatology
Foamy Histiocyte-Like Hepatocellular Carcinoma (HCC): A New Variant of HCC?
Richard Dunn, Wei Zhang, Jenny Z. Lai, Tyler Litton, Yihua Zhou, Jin-Ping Lai
Ann Hepatol. 2017;16:304-7
Open access
Case report
Drug-induced Liver Injury Caused by Ipragliflozin Administration with Causality Established by a Positive Lymphocyte Transformation Test (LTT) and the Roussel Uclaf Causality Assessment Method (RUCAM): A Case Report
Katsura Niijima, Yawara Niijima, Shuichi Okada, Masanobu Yamada
Ann Hepatol. 2017;16:308-11
Open access
Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus Treatment
Alicia Senín, Teresa Broquetas, Sabela Lens, Nuria Cañete, María-Carlota Londoño, Mariana Ferraro, Xavier Forns, Antonio Salar, Jose A. Carrión
Ann Hepatol. 2017;16:312-7
Open access
Obituary
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
